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Para ser grande, sê inteiro: nada 
Teu exagera ou exclui. 
Sê todo em cada coisa. Põe quanto és 
No mínimo que fazes. 
Assim em cada lago a lua toda 
Brilha, porque alta vive. 
 Fernando Pessoa, Poemas de Fernando Pessoa 
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“Searching for the neurobiological targets through which prenatal 
glucocorticoids program adult social and affective behaviors” 
Abstract 
Stress activates the hypothalamic-pituitary-adrenal axis and leads to a controlled 
release of glucocorticoids (GCs) in the blood stream. Due to their numerous effects, synthetic 
GCs are often prescribed in clinics, as for example in 10% of preterm risk pregnancies in order 
to accelerate fetal lung maturation. Previous studies have shown that exposure to stress, or 
administration of GCs during pregnancy can contribute for the development of neuropsychiatric 
disorders later in life such as anxiety, depression and addiction. 
In this work we studied a rat model prenatally exposed to synthetic GC, 
dexamethasone, at embryonic days 18 and 19. Animals were subjected to standard behavioral 
tests to assess emotional and social behaviors, and, to further complement these results we 
measured the emission of ultrasonic vocalization (USVs). iuGC animals are hyperanxious, 
display enhanced fear response and present depressive-like behavior. In parallel, we 
hypothesized that emotional impairment observed in iuGC animals could influence social 
interaction. Indeed, prenatal GC exposure impairs social behavior at different ages, since iuGC 
animals present low motivation to engage in social play and seem to present less pleasure 
during the interaction. Considering the cross-talk between opioid-endocannabinoid-
dopaminergic circuits in both emotional and social behaviors, we further analysed levels of 
specific receptors in several regions of mesolimbic circuitry. We found prominent changes in 
Drd2, MOR1 and KOR1 in the nucleus accumbens and amygdala, which may underlie the 
abovementioned impaired behaviors.  As these animals present a significant hypodopaminergic 
status in the mesolimbic circuitry, together with Drd2 molecular changes, in the last part of the 
project we decided to treat these animals with L-DOPA, a dopamine precursor. Administration 
of a therapeutic dose of L-DOPA reverted most of the emotional and social deficits observed in 
iuGC animals, suggesting a crucial role of dopaminergic transmission in this type of behaviors. 
Our results show that prenatal GC administration potentiates emotional and social 
deficits, probably as a consequence of a deficient dopaminergic signalling in the mesolimbic 
circuitry. Importantly, we were able to restrain these behaviors by a simple pharmacological 
approach. 
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“Explorar os alvos neurobiológicos através dos quais glucocorticoides pré-
natais programam comportamentos sociais e afetivos”  
Resumo 
O stress ativa o eixo hipotálamo-pituitária-adrenal e conduz à libertação de 
glucocorticoides (GCs) na corrente sanguínea. Devido aos seus efeitos diversos, os GCs 
sintéticos são usados frequentemente na prática clínica, como por exemplo em gravidezes 
com risco de parto pré-termo, para promover a maturação pulmonar fetal. Estudos anteriores 
demonstraram que exposição ao stress, ou a administração de GCs durante a gravidez, pode 
contribuir para o desenvolvimento de doenças neuropsiquiátricas em adultos, tais como 
ansiedade, depressão e adição.  
Neste trabalho estudamos um modelo em rato de exposição ao GC sintético, 
dexametasona, nos dias embrionários 18 e 19 (iuGC). Os animais foram submetidos a uma 
bateria de testes comportamentais para avaliar o comportamento emocional e social, e, de 
forma a completar estes estudos, também medimos a emissão de vocalizações ultrassónicas 
(USVs). Os animais iuGC são mais ansiosos, apresentam comportamento do tipo depressivo, e 
uma resposta ao medo exacerbada.  
Em paralelo, avaliamos o comportamento social e vimos que estes animais 
apresentam uma menor antecipação para iniciar uma interação social e menos prazer na 
mesma. Considerando a interação entre os sistemas opioide-endocanabinoide-dopaminérgico 
neste tipo de comportamento, decidimos analisar os níveis de determinadas moléculas destes 
circuitos nestes animais. Identificamos alterações proeminentes no receptor Drd2, no MOR1 e 
KOR1 no nucleus accumbens e na amigdala no grupo iuGC. Uma vez que os iuGC apresentam 
um estádio hipodopaminergico substancial no circuito mesolimbico juntamente com alterações 
significativas de Drd2, decidimos tratar os animais com um precursor da dopamina, a L-DOPA. 
Administração de uma dose terapêutica de L-DOPA reverteu quase todas as alterações 
comportamentais dos animais iuGC. 
Estes resultados mostram que a administração pré-natal de GCs potencia o 
aparecimento de déficits emocionais e sociais, e que uma simples abordagem farmacológica 
com o objectivo de aumentar a dopamina nestes animais, foi suficiente para reverter a maioria 
das alterações comportamentais.  
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1. Introduction 
 
1.1. Stress and the Hypothalamic-Pituitary-Adrenal (HPA) axis 
Stress is defined as any perturbation of homeostasis of the organism, both 
psychological or physiological (Goldstein and Kopin, 2007). The stress response is coordinated 
by the brain; in the presence of a stressor, adrenaline and noradrenaline are released, and this 
constitutes the foundation of the classic reaction of the “fight-or-flight” response (Juruena et 
al., 2004). Simultaneously, stress activates the hypothalamic-pituitary-adrenal (HPA) axis. This 
endocrine response starts with the release of corticotrophin-releasing hormone (CRH) that is 
secreted by neurons from the paraventricular nucleus (PVN) of the hypothalamus (HPT). The 
CRH acts on the anterior pituitary, where it stimulates the synthesis and release of 
adrenocorticotropic hormone (ACTH) into the blood stream. In turn, ACTH induces the 
synthesis and secretion of corticosteroids in the adrenal cortex (Fig.1). The main corticosteroid 
is cortisol in humans and corticosterone in rodents (Mesquita et al., 2009). 
 
Figure 1 - Regulation and negative feedback of glucocorticoids (GCs) in the hypothalamus-pituitary-adrenal (HPA) 
axis. Under stressful stimuli the cells of the paraventricular nucleus (PVN) in the hypothalamus release 
corticotrophin-releasing hormone (CRH). The CRH activates the pituitary, which in turn, releases 
adrenocorticotropic hormone (ACTH), then it act on the adrenal cortex resulting in an increase in the levels of 
glucocorticoids in the blood stream. GCs have a negative feedback in order to inhibit further production of GCs. 
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There are two types of corticosteroids receptors, the high-affinity mineralocorticoid 
receptor (MR) and the low-affinity glucocorticoid (GC) receptor (GR) (Sanchez et al., 2000). 
Ligand binding results in the translocation of the receptor to the nucleus, where it regulates the 
expression of target genes due to the association of the complex receptor-ligand with the 
glucocorticoid response elements (GREs) in the promoter region of targets genes (Fig.2). 
Importantly, the GRs can regulate positive or negatively the genes to which they are coupled 
(Juruena et al., 2004).  
 The cessation of the HPA response to stress is coordinated by a glucocorticoid 
negative-feedback process (Fig.1)(Spencer et al., 1998, De Kloet et al., 1998), which is tightly 
regulated to prevent deleterious effects of both hyper and hypo-cortisolemia. 
 
1.2. The physiological role of GCs  
Endogenous GCs (CORT) increase the concentration of glucose and other metabolic 
fuels; they are also involved in the immune response. GCs have inhibitory effects on both 
innate and acquired immune response mediated by the T and B cells, and can suppress the 
effector functions of phagocytes. In short, they are extraordinary efficacious in managing 
numerous acute disease manifestations of inflammatory and autoimmune disorders (Chatham 
and Kimberly, 2001). During pregnancy, they are involved in lung maturation (regulation of 
surfactant production by the lungs), and for the regulation of immune and metabolic functions, 
and for neuro- and behavioral development (Mesquita et al., 2009). 
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Figure 2 - Scheme of the activation of glucocorticoid receptor (GR). GR in their inactive state are present in the 
cytoplasm with a multimeric complex of chaperone proteins, including many heat sock proteins. Endogenous or 
synthetic glucocorticoids act as a ligand; GR-ligand undergoes a conformational change, and becomes active, then 
dissociates from the complex of chaperone proteins and translocates to the nucleus, where it regulates gene 
expression by binding to glucocorticoid response elements (GRE). The diagram is adapted from Strachan T., 1999 
(Strachan T. and A.P., 1999). 
 
The placenta as well as most foetal tissues expresses GRs, which can bind both 
endogenous and exogenous GC, from mid-gestation onwards (Johnson et al., 2008). 
Endogenous GCs have a higher affinity to MR and the expression of these receptors is more 
confined to specific brain areas and, in rodents, is only present in late gestation (Funder, 
1996). 
The foetus has limited capacity to degrade synthetic GCs, so, even low levels of GC can have a 
deleterious impact. The endogenous GCs are much lower in the foetus than in mother 
circulation due to the existence of the enzyme 11-Beta hydroxysteroid dehydrogenase (11β-
HSD), which is located in the syncytiotrophoblast, the site of maternal-foetus exchange 
(Mesquita et al., 2009). This enzyme converts the GC in 11-keto metabolites, its inactive form. 
Nonetherless, 11β-HSD is not active throughout the pregnancy, in fact, it was show by 
McTernan and collaborators, variations of 11β-HSD activity in the end of pregnancy, in rats and 
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humans (McTernan et al., 2001), that may indicate that increased maternal GCs during this 
stage can affect the foetus. Moreover, exogenous GCs, such as dexamethasone (DEX) or 
betamethasone, are poor substrates for 11β-HSD, facilitating the passage through the placenta 
(White et al., 1997). 
Due to their pleiotropic action and ability to cross the placenta, exogenous GCs are 
widely prescribed, in clinics, to accelerate lung maturation in preterm labour and perinatal 
period (Crane et al., 2003). Frequently, DEX, a synthetic glucocorticoid that has 25 times more 
potency than endogenous cortisol (Oliveira et al., 2006), is used in clinics. This seems to 
reduce neonatal death, respiratory distress syndrome (RDS), intraventricular hemorrhage, 
necrotizing enterocolitis (NEC) and respiratory support, intensive care admissions and systemic 
infections in the first 48 hours of life (Miracle et al., 2008). Less frequently, it is used during 
antenatal period in the foetuses at risk of congenital adrenal hyperplasia (CAH) (New et al., 
2001). Although the positive effects of such treatment are undeniable, less is known about the 
deleterious effects that it can have in the developing brain. 
 
1.3. GCs early in life: molecular, structural and behavioral outcomes 
Adversity during early life, including, abuse or neglect, can induce effects on physical 
and mental health. For example, it increases the risk of development of conduct disorders, 
personality disorders, major depression, schizophrenia, anxiety and addictive disorders (Agid et 
al., 1999, Bernet and Stein, 1999, Dube et al., 2003, Heim and Nemeroff, 2001, Young et al., 
1997). In contrast, the development of psychiatric disorders  is very low in women abused 
during adulthood (Brown and Moran, 1994), (McCauley et al., 1997). Thus, studies 
demonstrate that the mechanisms that underlie programming of the adult HPA axis function 
are dependent on time of exposure, but also, dependent of the dose of GCs. 
Some studies report that children exposed prenatally to GC have a reduction in their 
birth weight, and at the age of 3 present significant behavioural changes (Newnham, 2001). 
Oliveira and colleagues showed that prenatal administration of endogenous or synthetic (DEX) 
glucocorticoids can act permissively to accelerate some developmental processes, like eye 
opening (a measure of neurological development), while it delays others, like body growth 
(Oliveira et al., 2006), in rats.  However, such treatments lead to a long-lasting impairment in 
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the HPA axis (Matthews et al., 2002). In utero exposure to GCs/stress, and consequent 
impairment in the HPA axis, was found to be associated with long-lasting deficits in cognitive, 
mood and addictive behaviors (Oliveira et al., 2006, Rodrigues et al., 2011b, Roque et al., 
2011, Miracle et al., 2008). Indeed, in human pregnancies, evidence suggests that fetal 
exposure to synthetic GCs has detrimental effects on birth outcome, childhood cognition and 
long-term behavior (Seckl, 2004, Crowley, 1995, Miracle et al., 2008). Furthermore, previous 
work from our lab revealed that prenatal administration of DEX to rats induces a hyperanxious 
status in the progeny and increases the propensity for developing depression (Roque et al., 
2011), together with reward-associated behaviors (Rodrigues et al., 2011b). 
 Several brain regions seem to be affected by early exposure to GC, however,  the 
hippocampus (Sousa and Almeida, 2002), the prefrontal cortex (Cerqueira et al., 2007) and 
the bed nucleus of the stria terminalis (BNST) seem to be specially affected (Pego et al., 
2008). Previous work showed that rhesus monkeys treated with prenatal DEX present a 
reduction in hippocampal neuronal number and volumes, until de age of 20 months old (Uno 
et al., 1990).  Indeed, in humans and rats it has been demonstrated that alterations in 
hippocampus caused by elevated GCs during prenatal period, can be responsible for the 
development of depression in adulthood (Sheline et al., 1996, Stein et al., 1997). In addition, 
prenatal GCs administration leads to an increase in the levels of CRH in the amygdala (AMY), 
which in turn leads to the development of anxiety in adult life (Cratty et al., 1995). 
Interestingly, the mesolimbic circuit also known as reward circuit, seems particularly 
sensitive to early life stress (Leao et al., 2007, Rodrigues et al., 2011a). This pathway involves 
dopaminergic inputs from the ventral tegmental area (VTA) to the AMY and nucleus accumbens 
(NAcc), and is activated in consumatory behaviors such as sex, food and drug consumption, 
and it is generally characterized by increased dopamine (DA) release from the VTA to NAcc 
(Baier et al., 2012). In this context, it is important to quote that mesolimbic neurons are 
strongly activated upon stress or GC exposure (Rodrigues et al., 2011a), increasing the 
strength of excitatory synapses on DA neurons and inducing similar patterns of dendritic 
organization in the NAcc. This suggests that dopaminergic transmission in the NAcc is GC-
dependent (Barrot et al., 2000). McArthur et al showed that  rats exposed to GC prenatally, 
significantly increases adult dopamine neuronal numbers in the ventral tegmental area (VTA) 
(McArthur et al., 2005). These data confirm that mesencephalic dopaminergic neurons are 
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sensitive to perturbations in circulating GC levels during development (McArthur et al., 2005). 
On the contrary, previous work from our lab, show that GC treatment induced a reduction in 
proliferating cells and reduced number of TH-positive cells in the VTA, leading to a decrease in 
the dopaminergic (DAergic) innervation to the NAcc (Rodrigues et al., 2011a). Such changes 
may underlie the addictive profile of these animals and partially explain their anxious profile 
(Oliveira et al., 2006, Leao et al., 2007, Rodrigues et al., 2011a, Rodrigues et al., 2011b).   
Though several studies suggest that prenatal GCs affect emotional the status of 
individuals, less is known about its effects in terms of social behavior, which is the main focus 
of this thesis. 
 
1.4. Social Play Behavior  
Nothing is more familiar to mammalian species than their ordinary, everyday social 
interactions. Increasing evidence suggests that social support in humans, and affiliative 
behaviors in animals, can lead to a positive impact on health and decrease mortality from 
many different causes (DeVries et al., 2003). There are many forms of social behavior, but for 
the context of this thesis we will only focus on social play behavior. Social play behavior is one 
of the earliest forms of non-mother-directed social behavior appearing in animals, presenting a 
significant rewarding effect (Vanderschuren et al., 1997).  
In rats, social play behavior exhibits an inverted U-shaped curve, being the highest 
level around day 30 of life and declining following maturation (Trezza and Vanderschuren, 
2008b). Thus, social play is considered the most characteristic social behavior of adolescent 
animals (Panksepp et al., 1984). In juvenile rats, social interaction with a play partner displays 
various forms (Vanderschuren et al., 1997). Social play does not have the highest priority and 
is not displayed unconditionally, only appearing after the primary needs of animals have been 
satisfied. For example, food deprivation or exposure to intense light conditions suppres social 
play behavior (Siviy and Panksepp, 1985, Vanderschuren et al., 1995a). Previous studies have 
identified many behavioral acts during social play, which include pouncing, pinning and social 
exploration (Baenninger, 1967, Panksepp and Beatty, 1980). Pinning and pouncing are 
considered to be related with play behavior, while social exploration is not directly related with 
play (Vanderschuren et al., 1997). The social play behavior starts with one animal approaching 
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and soliciting another (pouncing), i.e., the soliciting rat attempts to nose or rub the nap of neck 
of the play partner. After this, pinning may follow. Pinning is defined as one of the animals lying 
with its dorsal surface on the floor with other animal standing over it. Thus, when a rat attempt 
to nose the nape of a conspecific, the pounced animal fully rotates to a supine position, 
pinning is the result (Vanderschuren et al., 1997).  
Social interaction is not only rewarding for the animals, but also seems to modulate 
emotionality, in both rats and humans (Burgdorf et al., 2011). Social interaction profoundly 
influences the HPA axis activity in humans and other animals. Severe psychosocial stress, or 
the lack of certainty and control over one’s social environment, can lead to chronically elevated 
HPA axis activity and a deterioration of health (DeVries et al., 2003, DeVries, 2002). This is 
supported by earlier work that had shown that rats were very susceptible to effects of social 
isolation during the period of weaning and maturation (Einon and Morgan, 1977, Einon et al., 
1978). Moreover, social defeat is one of the most powerful stress paradigms in rodents 
(McLaughlin et al., 2006). Animals that are deprived of play present abnormal patterns of 
social, sexual and aggressive behaviors (Gerall et al., 1967, Lore and Flannelly, 1977, 
Vanderschuren et al., 1997). The offspring of stress exposed pregnant female rats, during the 
final week of pregnancy, have a diminished quality the social interaction behavior indicative of 
a reduced social drive (Lee et al., 2007). Another study has shown that administration of DEX 
to pregnant rats on gestation days 6-8, leads to a decrease in juvenile social play (Kleinhaus et 
al., 2010). 
In summary, stress/GCs may affect the development and/or manifestation of correct 
social behavior. On the other hand, social deprivation may be a powerful stressor at crucial life 
stages. 
 
1.5. Modulation of social (and affective) behavior: neurobiological 
correlates 
Social play is the most characteristic expression of social activity, and it is modulated 
by neural systems involved in reward and motivation, such as the opioid and endocannabinoid 
sistems, and this seems to rely on a strong interplay with DAergic circuit (Trezza and 
Vanderschuren, 2008b).  
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1.5.1. Opioids signalling   
 The opioid receptors are a group of G-protein-coupled receptors, which has the opiods 
as ligands. The opioids are found principally in the central and peripheral nervous system and 
in the gastrointestinal tract (Mansour et al., 1995). Until now, three types of receptors have 
been identified, referred as µ, k and δ (MOR, KOR and DOR). With the use of selective agonists 
or antagonists, it became clear that each type of opioid receptor has unique pharmacological 
properties, is differentially distributed in the central nervous system and has been implicated in 
a broad range of behaviors and functions, such as, regulation of pain, reinforcement and 
reward, release of neurotransmitters, and neuroendocrine modulation (Leadem and Yagenova, 
1987, Schoffelmeer et al., 1988, Bozarth and Wise, 1984). Each opioid receptor type 
demonstrates a distinct anatomical distribution. The µ opioid receptor (MOR) is distributed in 
regions such as the septum, the BNST, the hippocampus, the medial preoptic area, the AMY, 
the locus coeruleus (LC), the parabranchial nucleus (PBN), the nucleus tractus solitarius (NTS) 
and the dorsal motor nucleus of the vaugus. The k opioid receptor (KOR) is present in regions 
such as the NAcc, the BNST, the medial preoptic area, the hypothalamus and the AMY. The δ 
opioid receptor (DOR) is located in the hippocampus, the AMY and the ventrolateral medulla 
(VLM) (Mansour et al., 1995). 
With respect to the HPA axis, it is known that opioid receptors are able to modify the 
release of specific hormones, such as, increase the release of corticosteroids or decreasethe 
release of oxytocin (OXY) (Mansour et al., 1995). There is strong evidence showing that 
administration of an opioid receptor antagonist induces a greater increment in the HPA axis 
function in chronically stressed animals when compared with control animals (Drolet et al., 
2001), suggesting that opioids have the effect of attenuating stress responses (defensive action 
of the organism). 
Apart from this role in the HPA axis activity, the opioids are important in the 
modulation of affective and social behaviors (Vanderschuren et al., 1995b). The opioids are 
released during episodes of social contact and rewarding situations, and can induce odor and 
place preference (Nelson and Panksepp, 1998, Trezza and Vanderschuren, 2008b). It was 
also shown by many studies that opioid release results in a powerful attenuation of the reaction 
to social separation (Nelson and Panksepp, 1998). On the other hand, low basal levels of 
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opioids induce motivation to seek out social contact (Panksepp et al., 1985, Vanderschuren et 
al., 1995b). 
Therefore, if the rat is treated with morphine it will increase social play. In contrast, an 
opioid antagonist decreases social play behavior (Trezza and Vanderschuren, 2008b). Actually, 
depending on the dose of morphine, it can have different effects on social behavior. Morphine 
treatment powerfully increases pinning, which indicates an increase in the rewarding properties 
of social play (Vanderschuren et al., 1997). When rats are tested in an unfamiliar environment, 
pinning and pouncing are initially suppressed, while the rats explore before engaging in social 
play, although the total levels of play are not affected. A dose of morphine 10 times lower than 
the dose used to increase social play, is capable to abolish the initial suppression of social play 
(Vanderschuren et al., 1997).   
It has been shown that all types of opioid receptors are involved in reward-related 
processes. The rewarding effects of opioid drugs are generally mediated by µ-opioid receptors 
along with evidences that had shown also that the δ-opioid receptor is important in reward 
processes (Depue and Morrone-Strupinsky, 2005, Le Merrer et al., 2009). Regarding k-opioid 
receptors stimulation, some reports have shown that it results in dysphoric effects (Mucha and 
Herz, 1985).    
Interestingly, it was found that the three types of opioid receptors have different effects 
on social behavior. The stimulation of µ- and k-opioid receptors has antagonistic effects. While 
the stimulation of µ-opioid receptor enhances social behavior, the opposite pattern was 
observed with k-opioid stimulation (Vanderschuren et al., 1995b). To what concerns the δ-
opioid receptor, neither δ-opioid receptor agonist nor δ-opioid receptor antagonists are involved 
in the regulation of social behavior. Some reports have shown that this is only observed in 
juvenile rats (Vanderschuren et al., 1995b). In adult rats, δ-opioid receptor agonists have been 
reported to increase social behavior (Negri et al., 1991).  
 
1.5.2. Cannabinoid signalling 
There are currently two subtypes of known cannabinoid receptors, cannabinoid 
receptor 1 (CB1) and cannabinoid receptor 2 (CB2). The CB1 receptor is expressed principally 
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in the central nervous system, but also in the lungs, liver and kidneys (Herkenham et al., 
1991). Within the brain, there are at least two endogenous ligands that activate the CB1 
receptor, namely N-arachidonoylethalamine (anandamine, AEA) and 2-arachidonoyglycerol (2-
AG) (Hill and Tasker, 2012). The CB2 receptor is expressed predominantly in the immune 
system and in the hematopoietic cells, but recent reports also show their expression in the 
brain (Gong et al., 2006). 
With respect to the HPA axis, it is know that the endocannabinoid system is well 
distributed throughout cortico-limbic and hypothalamic circuitries, which regulates the 
activation of HPA axis (Gorzalka et al., 2008). The endocannabinoid system has been found to 
regulate both excitatory and inhibitory neurotransmitter release in the circuitry (Hill et al., 
2010). Mice deficient in CB1 receptors or animals treated with a CB1 receptor antagonist 
present an increase in the basal activity of the HPA axis (Hill and Tasker, 2012). After a period 
of acute stress, CB1 knock out (KO) mice exhibit a larger peak of ACTH and corticosterone 
response, suggesting that the loss of CB1 receptor reduces the fast feedback inhibition and 
increases the magnitude and duration of the HPA axis response to acute stress (Barna et al., 
2004). In addition, endocannabinoids (eCBs) play an important role in glucocorticoid-mediated 
negative feedback (Hill and Tasker, 2012). Interestingly, the endocannabinoid system appears 
to contribute differently to the feedback loops of GC feedback inhibition of the HPA axis and 
does so through distinct mechanism. Within the PVN, glucocorticoids cause a rapid release of 
endocannabinoids, which contribute to a fast-feedback inhibition of the HPA axis. Within the 
prefrontal cortex (PFC), GCs cause a delayed increase in endocannabinoid mobilization, which 
contribute to a delayed GC negative feedback of the HPA axis. Combined, this different 
recruitment of the endocannabinoid system leads to a both short (PVN) and long (PFC), loops 
of the negative feedback pathway in the brain (Hill and Tasker, 2012). 
Besides the modulation of the HPA axis activity, cannabinoid neurotransmission is 
important in reward processes, and interacts with the opioid system in the modulation of drug, 
food and social reward (Trezza and Vanderschuren, 2008a, Solinas and Goldberg, 2005, 
Fattore et al., 2005). Tezza and Vanderschuren have shown that the cannabinoid system has 
an important role in the modulation of social play behavior, with opposite behavioral results 
depending on how the endocannabinoid system is stimulated (Trezza and Vanderschuren, 
2008a). The direct CB1 cannabinoid receptor agonist and the indirect cannabinoid receptor 
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agonist exert opposite effects on social behavior (Trezza and Vanderschuren, 2008a). 
Preclinical reports revealed that both acute and chronic treatment with cannabinoid receptor 
agonist suppress social behavior (Schneider et al., 2008). In addition, the indirect cannabinoid 
receptor agonist, which inhibits fatty acid amide hydrolase (FAAH), the enzyme that degrades 
the endocannabinoid, anandamide, enhances social behavior. Reports have also shown that 
this indirect cannabinoid receptor agonist is dependent on opioid and dopaminergic 
neurotransmission, and it is blocked by antagonists of both systems (Trezza and 
Vanderschuren, 2008a). 
Previous reports have exposed that the endocannabinoid and opioid systems interact 
with each other (Trezza and Vanderschuren, 2008b). Actually, it has been shown that the 
endocannabinoid system is involved in the reinforcing and dependence-producing properties of 
opioid drugs. Vanderschuren was the first to show an interaction between these two circuits in 
the positive modulation of social behavior (Trezza and Vanderschuren, 2008a, Trezza et al., 
2012). It was also observed that the increase in social play induced by the indirect cannabinoid 
receptor agonist was completely block by opioid receptor antagonist, and surprisingly, the 
increase effect of morphine on social play behavior was reduced by CB1 cannabinoid receptor 
antagonist (Trezza and Vanderschuren, 2008a). 
 
1.5.3. Dopaminergic signalling 
The dopamine (DA) receptors are G-protein-coupled receptors. There are 5 types of DA 
receptors (Drd 1-5). The Drd1 is the most widespread of the DA receptors and is expressed at 
higher levels than the other types of DA receptors (Baier et al., 2012). It has been found in the 
NAcc, AMY, caudate putamen (CPu) and in the prefrontal cortex (PFC). On the other hand, D5 
receptor, also called Drd1-like receptor, is less expressed in the rat brain in comparison to the 
Drd1 subtype, and it is expressed in the frontal cortex, hippocampus and CPu. The three Drd2-
like type of receptors Drd2, Drd3, and Drd4 are all expressed in the NAcc, and olfactory 
tubercle, amongst other areas (Missale et al., 1998, Xu and Zhang, 2004) 
Dopaminergic circuitries can be divided into four main groups: nigrostriatal, 
mesolimbic, mesocortical, and tuberohypophyseal circuits (Fig.3). The first is the major 
dopaminergic tract in the brain, and plays an essential role in the control of voluntary motor 
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movement (Baier et al., 2012). The mesolimbic dopaminergic circuit originates in the cell 
bodies localized in the VTA and projects to NAcc, AMY and hippocampus. Other group of cell 
bodies in the VTA project to the prefrontal and perirhinal cortex, forming the mesocortical 
dopaminergic system. Previous reports have shown that these last two pathways overlap 
substantially, and are collectively referred as the mesocorticolimbic system, being involved in 
emotional behaviors including motivation and reward (Chinta and Andersen, 2005). In addition, 
these neurons have been hypothesized to play a critical role for the action of antipsychotic, 
antihyperactivity and psychostimulant drugs (Baier et al., 2012). Lastly, the tuberohypophyseal 
system, which is originated in the hypothalamus and innervates the pituitary and the median 
eminence, is important in the regulation of the release of pituitary hormones (Baier et al., 
2012).  
 
Figure 3 - Schematic representation of dopaminergic pathways. Dopaminergic transmition can be divide in four 
pathways nigrostriatal, mesolimbic, mesocortical, and tuberohypophyseal systems. The diagram is adapted from 
Baier CJ, 2012 (Baier et al., 2012). 
 
Work from Kuhn et al showed that Drd1 and Drd2 subtypes of DA receptors contribute 
for the dopaminergic regulation of the HPA axis function, and stimulated increase the HPA axis 
response (Borowsky and Kuhn, 1992). Besides modulation of the HPA axis, dopamine is also 
important for the regulation of emotional, affective and social behaviors (Rodrigues et al., 
2011b, Vanderschuren et al., 1997), although, the role of the dopaminergic neurotransmission 
in the modulation of social play is not yet clear. It has been reported an increase and decrease 
on social play behaviour, after treatment with dopamine receptor agonists(Siviy et al., 1996, 
Vanderschuren et al., 1997). Part of the rewarding properties of both opioid and cannabinoid 
drugs involve dopamine-dependent processes, through direct interaction with 
dopaminoreceptive neurons in the NAcc (Pierce and Kumaresan, 2006). Complementing this, 
15 
 
it was shown by Vanderschuren and colleagues that the effects of the indirect endocannabinoid 
receptor agonist were blocked by the dopamine receptor antagonist, while those of morphine 
were not (Trezza and Vanderschuren, 2008a). These results indicate that although the 
endocannabinoid and opioid systems jointly facilitate social play, they do so through partly 
dissociable mechanism. The opioid and dopaminergic circuits also seem to interact and 
modulate the reward behavior (Berridge, 2007, Depue and Morrone-Strupinsky, 2005). 
Whereas, the mesolimbic dopaminergic system mediates the motivation to a reward, opioids 
modulate the pleasurable proprieties of a rewarding situation (Berridge, 2003, Kelley et al., 
2005, Berridge, 2007). Indeed, there are significant studies showing that the rewarding 
aspects of social interaction depend on opioid activity (Depue and Morrone-Strupinsky, 2005). 
Actually, there are many reports evidencing the interaction between opioid and dopaminergic 
system in social bonding and sexual behavior (Balfour et al., 2004, Young and Wang, 2004).  
 
1.6. Ultrasonic vocalizations – a measure of emotional and social behavior 
in rodents    
Emotional and social behaviors are complex and dynamic and its analysis presents 
some limitations when using animal models. In the context of this thesis, we decided to 
complement the behavioral studies with the recording of ultrasonic vocalizations (USVs). 
Rats use USVs as a regular feature of their social interactions. Social interactions 
include aversive and appetitive encounters and the measurement of such USVs can be used an 
indicative of their emotional status and social capacities (Knutson et al., 1998).  
Rat vocalizations are produced through the larynx. Rats use their larynx in two modes: 
the first, to produce audible sounds of 2-4kHz, by causing vibrations of vocal folds (Nitschke, 
1982); And the second, generates USVs, in this case, the larynx is stabilized and used as 
whistle with a very small orifice created by the vocal cords, which cannot vibrate (I. et al., 
2001). This produces the ultrasonic sound by the same principle as a human whistle does, 
except that the small size of the respiratory tract of the rat produces sound in the ultrasonic 
range.  
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It is possible to identify three classes of USVs that the rat uses in different situations. 
Rat pups show evidence of ultrasonic vocalizations around the 40 kHz in response to situations 
like separation from their litters and mother, or even when the temperature of the environment 
drops (Hofer, 1996). Adolescent and adult rats emanate two different kinds of USVs, classified 
according to their frequency, as low (22 kHz) and high (50 kHz) frequency ultrasonic 
vocalizations. 
In situations of danger, circumstances that originate an increase of anxiety (for 
example, in the presence of an aggressive opponent, predator, large mammal or when the 
noise is loud), or even when the rat is expecting an unpleasant stimulus, it emits 22 kHz alarm 
calls, also called as low frequency vocalizations (Brudzynski, 2009). These kinds of sounds are 
significant advantages in the present of some predators that do not have the capacity to hear 
ultrasonic vocalizations. Furthermore, these ultrasounds are propagated more directionally 
than audible sound, they are difficult to detect and localize, and they dissipate easily in 
environmental obstacles and weather conditions. And if these sounds are emitted in 
underground burrows the predators in the ground or in the air do not hear it (Brudzynski, 
2009). Such vocalizations are not only emitted during the actual aversive event and in 
response to stimuli associated with these experiences but also in situations of sexual contact 
(Knutson et al., 1999). The intensity of an aversive emotional state can be revealed by 
latencies to pronounce vocalizations, their length and loudness or by the number of calls 
emitted (Wohr et al., 2005).  
High frequency 50 kHz USVs occur in situations associated with a positive status and 
are representative of a state similar to joy (Knutson et al., 1999). They are expressed in rough-
and-tumble play, tickling, exploratory activity, meeting rats after a period of separation or in the 
initial meeting of resident-intruder pair and in rewarding situations (Brudzynski, 2009, 
Brudzynski and Chiu, 1995). It was observed that these sounds are also emitted in the 
presence or anticipation of artificial rewarding situations, like pharmacological stimulus (Maier 
et al., 2010, Burgdorf et al., 2000).  
Besides appetitive situations, 50 kHz USVs also occur after separation from 
conspecifics during short periods of social isolation. Rats taken out from their home cage and 
individually exposed to a clean cage, as well as the rat that stays alone in the home cage after 
the conspecifics has been removed, emit 50 kHz USV (Wohr et al., 2008). Actually, the fact 
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that the separation from conspecifics elicits 50 kHz USV is an indicative of an affiliative 
communicative function of positive USV, namely to (re)establish or to maintain social contact. 
It is important to mention, that is possible for the rats to emit with a brief difference of 
time both types of call, but they cannot acoustically mix the 22 kHz and 50 kHz ultrasounds. 
These mutually exclusive types of vocalization are regulated by two ascending systems that 
originate in the brainstem tegmentum: the cholinergic system and the mesolimbic 
dopaminergic system (Fig.4) (Brudzynski, 2009).  
      The activation of the cholinergic system, which originates in the laterodorsal 
tegmental nucleus and extends to the basal forebrain and limbic areas (Fig.4, black arrows), 
induces defensive behavior and increases the number of 22 kHz ultrasonic vocalizations. It was 
shown that pharmacologic treatments, that activate this system, induce 22 kHz USVs and the 
use of antagonists inhibits or decreases these USVs, resulting in a negative affective state 
(Brudzynski, 2001).  
The ascending dopaminergic system, that begins in the VTA and ends in the NAcc and 
other basal forebrain structures (Fig.4, white arrows), when activated induces behavioral 
activation (increase in locomotor activity and exploration) and increases 50 kHz vocalizations, 
resulting in a positive affective state. This state includes relevant changes in the somatic, 
autonomic, and endocrines systems (Brudzynski, 2009).  
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Figure 4 - Two ascending systems are responsible to initiate the ultrasonic vocalizations. The cholinergic system 
has the origin in the laterodorsal tegmental nucleus (LDT), and release acetylcholine in the anterior hypothalamus 
(AH), preoptic area (PO), bed nucleus of the stria terminalis (BNST), and lateral septum (LS), and has been 
involved in 22 kHZ USVs emission. The ventral tegmental area (VTA) is the zone of origin of the dopaminergic 
system. Release dopamine in the nucleus accumbens (NAcc) and neighboring areas, inducing 50 kHz 
vocalization. The diagram is adapted from Brudzynski SM. 2009 (Brudzynski, 2009). 
 
Due to the potential of the USVs to ascertain the emotional and motivational status of 
the animals, in this thesis we decided to complement the behavior studies by measuring this 
tool. 
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2. Aims 
 
Accumulating evidence suggests that high levels of GCs during prenatal period 
increase the propensity to develop a multiplicity of psychiatric disorders in adulthood, such as 
anxiety and depression.  
This project aims to characterize in detail the emotional, social and affective behaviors 
of adult animals exposed to GCs at gestation days 18 and 19. To further complement the 
standard behavioral tests, we will also evaluate the number and type of ultrasonic vocalizations 
(USVs) to ascertain emotional/effective condition in specific behavioral paradigms. As a last 
part of the project, we intend to identify the neurobiological correlates of such deficits.  
The present thesis had the following objectives: 
1. Establish and optimize USV measurement at ICVS; 
2. Evaluate emotional and social behaviors of iuGC animals in conjunction with USVs 
recordings; 
3. Ascertain the levels of specific neurotransmitter receptors (opioids, 
endocannabinoids and dopamine) in the mesolimbic circuits of iuGC animals; 
4. Revert the behavioral deficits by pharmacological manipulate of affected circuits. 
We expect that this integrative and multimodal analysis will give insight to the 
mechanisms underlying stress-induced social and emotional dysfunction and will shed some 
light about the neurotransmitter system(s) affected. 
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3. Materials and methods 
 
3.1. Animals 
All manipulations were conducted in accordance with local regulations (European 
Union Directive 2010/63/EU) and National Institute of Health guidelines on animal care and 
experimentation. Pregnant Wistar rats were injected with the synthetic GC, dexamethasone 
(DEX; iuGC animals), at 1mg kg-1 or with saline (CONT; control animals), on days 18 and19 of 
gestation. 
Male offspring were pair housed, according with antenatal treatment, under standard 
laboratory conditions: artificial 12h light/dark cycle (lights on from 08:00 a.m. to 08:00 p.m.); 
room temperature 22ºC; food and water were provided ad libitum.  
 
3.2. Experimental design  
Different sets of animals were used during the experimental approach, represented in 
fig.5. All procedures were performed during the dark period (08:00 p.m.- 02:30 a.m.), except 
the protocol to assess maternal behavior, the forced swimming test and the light/dark box test.  
Animals were assessed for social behavior at different ages (Fig.5). In adulthood, we 
analysed their emotional status using different behavioral paradigms to assess anxiety, 
depressive-like behavior and fear. A set of animals was sacrificed and brain areas (AMY, NAcc 
and HPT) were collected to be used for western blot analysis.  
Finally, we tried to reverse the phenotype by pharmacological manipulation. 
 
Figure 5 - Schematic representation of the experimental approach. 
Dexamethasone
(1mg/kg) or saline
injection on pregnant rats
PND1 PND21 3 months Sacrifice
Pups:
-Social Behavior
Maternal Behavior.
Juveniles:
-Social Behavior:
Tumble and play;
Adults:
-Emotional Status:
FST;
Physical enrichment;
Anticipatory behavior
to food;
L/D box test;
Fear conditioning;
-Communicative
function.
Western blot
Pharmacological reversion  of  the phenotype
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3.3. Behavioral characterization 
3.3.1. Emotional Status 
3.3.1.1. Forced swimming test  
The forced swimming test (FST) apparatus consists in a glass cylindrical tank, which 
was filled with water (24 ± 1ºC) to the depth enough so the animals could not support 
themselves by placing the paws or tail on the base of the cylinders. The water was cleaned 
between trials. 
On the first day (pre-test day) and second day (test day), rats were placed inside the 
cylinder for 5 min (Roque et al., 2011). On both days, UVS and behavior was recorded but only 
the second day was scored. The characteristics assessed were climbing time, immobility time 
(when the rat is floating in the water), and latency to be immobile.  
 
3.3.1.2. Physical Enrichment  
The apparatus consisted in an arena with 43.2x43.2 cm, with transparent acrylic walls 
and white floor (MedAssociates). Adult rats were individually habituated to the arena for 10 min 
with toys for two consecutive days. On the testing day, the animals were social isolated for 3.5 
h before testing (Trezza and Vanderschuren, 2008b). After this period, the animals were 
individually placed in the arena with toys for 10 min. Immediately after, the ultrasonic 
vocalizations were recorded. Before each trial, the apparatus was cleaned with Ethanol 10%, in 
order to remove odor from the previous animal.  
 
3.3.1.3. Anticipatory behavior to food (feeding sessions) 
The feeding sessions protocol was carried out for seven days as described previously 
(Burgdorf et al., 2000). Testing occurred in cages similar to their home cages. The testing box 
measured 30x20x30 cm, with a steel grid and approximately 3 cm of wood shavings covering 
the floor. During 6 consecutive days, the subjects were allowed to access food for 1hr per day. 
In the beginning of the test, the subjects were placed individually in the testing cage. After 3 
min (basal situation), a white light located 10cm above the floor was turned on and it stayed on 
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(‘cue exposure’) during 2 min, until the beginning of the feeding session, when they received a 
recipient full of food. On the seventh day, after the 2 min with a light on, instead of receiving 
food, an empty recipient was placed inside the testing box (‘extinction’). USVs were recorded 
throughout the days, during the cue exposure and extinction periods. After the seventh day, the 
subjects were allowed to access food ad libitum. 
 
3.3.1.4. Light/dark box test  
The light/dark box test (L/D test) was performed inside the open field arena 
(43.2x43.2 cm, transparent acrylic walls and white floor) (MedAssociates Inc., St.Albans, 
Vermont). The animals were individually placed in the center of the illuminated part. A dark 
compartment was attached to one side with an opening facing the center of the open field. The 
distance travelled and time spent in each compartment were recorded in a single-trial of 10 
min.  
 
3.3.1.5. Confined cage test 
The confined cage test was performed in a non-restrictive Plexiglas cylinder (inner 
diameter 8.8 cm, length 22.2 cm), mounted on a Plexiglas platform and placed in a ventilated, 
sound-attenuated chamber (SR-LAB, San Diego Instruments, San Diego, CA, USA). Inside of the 
cylinder was placed a stainless steel grid, through which an electric current could be passed 
(shock chamber). The microphone and a video camera were placed inside the sound 
attenuated chamber. The protocol was realized in two consecutive days, where the animals 
were placed inside of the shock chamber for 11 min. The USVs and percentage of total time 
freezing (total time which the animal didn’t move) were measured. Percentage of total time 
freezing was calculated as the probability of the time freeze of an animal by the total time in 
the chamber. Chambers were cleaned between tests (ethanol 10 %) in order to remove 
olfactory cues. 
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3.3.1.6. Fear conditioning 
The fear conditioning test was performed in the same apparatus as the confined cage 
test. The protocol was realized in three consecutive days (Borta et al., 2006). During the first 
day (habituation), each animal was placed in the sock chamber for 11 min. On conditioning 
day (second day), each subject was positioned again inside of the shock chamber. After the 
first 3 min, where no light or shock was given, the animal was exposed to six lights on/shock 
pairings, each followed by an inter-stimulus interval (ISI) of 60s. This shock (0,4mA ± 0,1) was 
administered during 500ms, after the period (20s) with the light on. Following conditioning, 
animals return to their home cages. 
 In the following day (test day), the animals were again placed in the shock chamber 
for 11 min. After the initial phase of 3 min, the light (3 W, incandescent light bulb) was 
presented six times for 20s each but not shock was given, again with an ISI of 60s. During all 
procedures USVs and behavior (freezing) were recorded. Percentage of total time freezing was 
calculated as the probability of the time freeze of an animal by the total time in the chamber. 
Chambers were cleaned between tests, as mentioned before. 
 
3.3.2. Social behavior 
3.3.2.1. Maternal Behavior 
Maternal behavior was assessed on postnatal days (PND) 3, 7 and 15. The mothers 
and pups (litters) were measured together in their home cage (basal situation), during 5 min 
(Hofer and Shair, 1978). The procedure was performed during the light phase (08:00 a.m.) 
and during dark phase (08:00 p.m.). 
 
3.3.2.2. Tumble and play 
Tumble and play test (Trezza and Vanderschuren, 2008b) was performed in cages 
similar to their home cages, which measured 30x20x30 cm, with approximately 2 cm of wood 
shavings covering the floor. For behavior recordings a camera with zoom lens was used. The 
characteristics of the social behavior scored were: pouncing (this is an index of play solicitation, 
i.e., when one of the animals is attempting to nose or rub the nape of the neck of the test 
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partner), pinning (when one of the animals is lying with is dorsal surface on the floor with the 
one animal on top of him) and social exploration (when animals are sniffing any part of the 
body, including the anogenital area, of the test partner). Play response to solicitation was 
calculated as the probability of an animal of being pinned in response to pouncing by the test 
partner.  
Juvenile rats were socially isolated for 3.5 h before testing. Each animal was then placed 
into the test cage with their sibling pair for 15 min. This protocol was performed three times. 
On the first trial, two familiar animals living in the same cage (from the same exposure group) 
were tested (familiar pairs). On the second trial, two unfamiliar animals (from the same 
exposure group) were tested (unfamiliar pairs). Lastly, we tested social interaction between one 
CONT animal and one iuGC animal (CONT-iuGC pairs). Besides behavior, we also measured 
the positive USVs during 15 min of the test, immediately after the animals were placed in the 
test cage. 
 
3.3.2.3. Communicative function  
In order to assess the social interaction in adult animals, we isolated one animal from 
the home cage and individually exposed it to a clean new cage for 15 min. During this time we 
recorded the USVS from the two animals, i.e., from the one isolated and the remaining animal 
in the home cage. After this period, animals were reunited and, once again, USVs were 
recorded, along with their social behavior (pinning, pouncing and social exploration) throughout 
the 15 min of the test. 
 
3.3. Western Blot 
Specific areas (AMY, NAcc and HPT) were collected by macrodissection, and 
subsequently frozen at -80ºC.  For western blot, lysis buffer (50 mM Tris  pH 7.4,  50 mM 
EDTA, 50 mM NaCl, 100 mM phenylmethylsulfonyl fluoride, complete protease inhibitors)  was 
added to each frozen area. After, samples were manually homogenized and centrifuged at 13 
000 r.p.m. for 10 min at 4ºC. The supernatant was collected and quantified using the Bradford 
method. Fifty µg of protein was loaded into a SDS-polyacrylamide gel, and gel was then 
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transferred to a nitrocellulose membrane. After, membranes were incubated overnight at 4ºC 
with the primary antibodies: rabbit anti-k opioid receptor 1 (1:2500, Invitrogen), rabbit anti-µ 
opioid receptor 1 (1:1000, Invitrogen), rabbit anti-dopamine D1 receptor (1:2500, Abcam), 
rabbit anti-dopamine D2 receptor (1:1000, Abcam) and rabbit anti-endocannabinoid receptor 1 
(1:500, kindly provided by Ken McKenzie). After incubation with the secondary antibodies, 
membranes were developed with luminol reagent (SantaCruz). Films were analyzed using 
ImageJ software.    
 
3.4. Pharmacological reversal of behavioral alterations 
L-DOPA/carbidopa (Sinemet, Merck, NJ, USA) was administered daily, 4h before 
testing, at a dose of 24 mg kg-1 (in water) by oral gavage. 
The administration of L-DOPA/carbidopa started three days before the animals being 
tested for emotional behavior (FST, food sessions- anticipation behavior, fear conditioning), 
social and affective behaviors (tumble and play) and also for communicative function. 
 
3.5. USVs analysis 
An Ultrasound Microphone (CM16/CMPA, Avisoft Bioacoustics, Berlin, Germany) 
sensitive to frequencies of 10-200 kHz, was used, 20 cm above the floor, in all experiences. It 
was connected via an Avisoft UltrasoundGate 416H (Avisoft Biocoustics) to a personal 
computer. Vocalization was recorded using the Avisoft-Recorder (version 5.1.04) with the 
following settings: sampling rate: 250000; format: 16 bit. For acoustical analysis, recordings 
were transferred to Avisoft SASLab Pro (version 5.1.22, Avisoft Bioacoustics). This program 
was used in order to produce spectrograms of USVs by conducting a fast Fourier 
transformation (256 FFT-length, 100% frame, Hamming window filter, 50% time window 
overlap). These spectrograms had a frequency resolution ~1.2 kHz and a temporal resolution 
~0.4ms.  
Twenty-kHz call detection was provided by an automated threshold-based algorithm 
(threshold: -40 dB) and a hold time mechanism (hold time: 20 ms). A lower-cut-off-frequency of 
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18 kHz was use to reduce background noise. For detection of 40 kHz was used an automated 
threshold-based algorithm of  -50 dB, an hold time of 10 ms and a high pass of 30 kHz (lower-
cut-off-frequency). In support of 50 kHz call detection, it was used the same threshold (-40 dB) 
as the 20 kHz USVs, but a hold time of 5 ms and a lower-cut-off-frequency of 40 kHz. 
Calls were also inspected manually to ensure that, when necessary, USVs not detected 
automatically could be subsequently included in the automatic parameter analysis. Various 
parameters, including peak frequency, peak amplitude and bandwidth, which were determined 
for each element of the entire spectrogram, were determined automatically. Temporal 
parameters determined included latency to call, call duration and the duration of intervals 
between subsequent calls. Finally, the total number of calls emitted was scored.   
 
3.6. Statistical analysis 
Statistical significance was determined using the GraphPad Prism 5 software. All data 
were represented as mean + SEM. Data were verified for Gaussian distribution. Unpaired t-
tests was use to determine whether CONT and iuGC animals differ in USVs production and 
behavior during tumble and play, EPM, FST, L/D box, and fear conditioning tests. When no 
Gaussian distribution was assumed, we used a nonparametric test (Mann-Whitney U-test).  
An two-way ANOVA for repeated measurements was used to test the differences 
between groups throughout time during the anticipatory behavior to food and physical 
enrichment tests. Significance is referred as * for P < 0.05, ** for P <0.01, *** for P <0.001.  
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4. Results 
 
4.1. Effects of iuGC treatment on emotional behavior of offspring 
Previous works from our lab have shown that in utero glucocorticoid (iuGC) exposure 
impairs emotional behavior, leading to an anxious phenotype, depressive-like behavior and 
drug-seeking behavior (Oliveira et al., 2006, Pego et al., 2008, Rodrigues et al., 2011b, Roque 
et al., 2011). To further characterize these animals, we implemented a new technique at the 
ICVS, which is the measurement of USVs (ultrasonic vocalizations), allowing to combine 
behavioral assessment and USVs emissions. 
 
Depressive-like-behavior 
In order to assess depressive-like behavior, animals performed the forced swimming 
test (FST). As expected, iuGC animals presented an increase in total time immobile (Fig.6, 
t=4.095, P=0.0005), decreased latency to immobility (Fig.6, t=2.207, P=0.038) and reduced 
climbing (Fig.6, t=3.387, P=0.0027) when compared with CONT animals.   
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Figure 6 - Prenatal administration of iuGC leads to depressive-like-behavior in the FST test. iuGC present 
increased immobility time, decrease latency to immobility and reduced climbing time. nCONT=12; niuGC=12; 
CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001. 
 
Depression leads to a lack of motivation and diminished pleasure feelings (Frank et al., 
2007, Der-Avakian and Markou, 2012). In order to assess motivation/pleasure, we analysed 
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the emission of USVs in an enriched environment in socially isolated animals. In addition, we 
also measured USVs in response to a cue that anticipates food in food deprived animals. 
During the enrichment test (arena with toys), iuGC animals emitted less 50 kHz USVs 
when compared with CONT (Fig.7, F1,41= 5.58, P=0,023), this difference was more accentuated 
in the initial day. 
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Figure 7 - Prenatal administration of iuGC leads to a diminished affective state in a novel enriched environment. 
iuGC emitted less 50 kHz USVs than CONT animals, throughout time. nCONT=8; niuGC=8; CONT=Controls; iuGC=in 
utero glucocorticoids.  
 
Relative to anticipatory behavior to food, animals were exposed to a cue, in this case a 
light, for 6 consecutive days, that predicted a bowl of food, and during this period the USVs 
were measured. Both groups increased the emission of positive calls over time (Fig.8A, 
F5,82=5.83, P=0,0001), suggesting that they learned the task. Over the days, number of USVs 
was substantially different between groups, with the iuGC animals emitting significantly less 
USVs than CONT animals (Fig.8A, F1,82=13,95, P=0.0003). On the seventh day, we also 
measured the USVs during the extinction period, i.e., after the light was off, the animal was 
presented with an empty recipient. Comparing both groups during cue exposure and extinction 
period, we observe that CONT rats emitted less in the second period (Fig.8B, t=2.659, 
P=0.0187), whereas the iuGC subjects emitted approximately the equal number of calls in the 
two periods (Fig.8B, t=0.7442, P=0.4691). 
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Figure 8 - Prenatal administration of iuGC leads to a lack of motivation/pleasurable feelings in anticipation to 
food. (A) Number of positive calls over the six consecutive days, during cue exposure, emitted by iuGC and CONT 
rats. Both animals increase the emission of positive calls over time although iuGC emitted less than CONT 
animals. (B) Number of 50 kHz USVs, during cue exposure and extinction periods (7th day). iuGC animals emitted 
almost the same number of USVs in the two periods, while the CONT emitted significantly less in the second 
period when compared with the first. nCONT=8; niuGC=8; CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** 
P <0.01, *** P <0.001. 
 
Anxiety 
In order to assess if iuGC treated animals presented an anxious phenotype, we 
performed the light/dark box test. iuGC spend more time in the dark box than CONT animals 
(Fig.9A, t=2.215, P=0.0407). Regarding the distance travelled during the test, no differences 
were found (Fig.9B, dark: t=1.384, P=0.1854, light: t=1.825, P=0.0867). 
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Figure 9 - Prenatal administration of dexamethasone leads to the development of anxious phenotype. Time (A) 
and distance (B) covered during the light/dark box test. iuGC animals spent more time in the dark box compared 
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with CONT, concerning the distance no differences were found. nCONT=10; niuGC=10; CONT=Controls; iuGC=in utero 
glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001.  
An additional paradigm was performed in order to assess the anxious phenotype. Adult 
animals were placed inside of a novel and confined cage for 11 min. Control animals emitted 
very few negative 22 kHz calls, but iuGC animals emitted significantly more (Fig.10A, U=9, 
P=0.0202). Regarding freezing behavior, no differences were found (Fig.10B, t=0.06417, 
P=0.9498). After habituation to the test box, iuGC animals no longer emitted 22 kHz 
vocalizations (Fig.10A), and a slight decrease in the percentage of freezing was observed 
(Fig.10B, U=25.5, P= 0.8162). 
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Figure 10 - Prenatal administration of dexamethasone leads to the development of an anxious phenotype. 
Number of 22 kHz calls (A) and percentage of freezing time (B) in a novel and confined cage. iuGC animals in an 
anxiogenic environment emitted more negative calls than CONT, while no differences were found  in the freezing 
behavior, on the first day. In the second day, both groups did not emit any 22 kHZ calls, and no differences were 
found in the percentage of freezing. nCONT=8; niuGC=8; CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** 
P <0.01, *** P <0.001. 
 
Fear 
We also assessed fear behavior, by conditioning the animals to a cue (light) paired with 
electric shocks. After the first 3 min of cage habituation, we did not observe either emission of 
negative calls or any time immobile. During the period of 6 light/shock pairs, as expected, both 
groups emitted several 22 kHz calls and spent more time immobile than in the initial phase, 
but iuGC to a greater extent (Fig.11A, t=2.611, P=0.0242; Fig.11C, t=2.355, P=0.0336, 
respectively). On the following day, the test day, animals were exposed to a cue again, but no 
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sock was given. In the initial phase (0-3 min), both animals spent slightly more time immobile 
and emitted more negative vocalizations than on the day before (Fig.11D and Fig.10B, 
respectively). On the next phase, cue exposure elicited more negative USVs and increased 
freezing time in both groups, but once more, iuGC rats were over reactive (Fig.11B, t=3,441, 
P=0.0063; Fig.11D, t=2.858, P=0.0126, respectively). 
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Figure 11 - Prenatal administration of GC leads to accentuated fear behavior. Number of 22 kHz USVs emitted 
during conditioning day (A) and test day (B). Percentage of time freezing during conditioning day (C) and test day 
(D). In the conditioning day, after the initial phase, the animals were submitted to 6 pairs of light/shock, both 
number of 22 kHz calls and percentage of freezing time increase in both groups, with a higher increase in iuGC 
animals. On the test day, animals were exposed 6 times to cue but without shock. We observe an increase in the 
number of USVs and in freezing time, and iuGC animals remain hyper-reactive. nCONT=8; niuGC=8; CONT=Controls; 
iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001.  
 
By analyzing the number of 22 kHz USVs during time in the test day, it was possible to 
confirm that iuGC animals emitted more negative calls than control group throughout the 
session (Fig.12). Following the first time that light was ON, both groups increased the number 
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of vocalizations, but after the second cue exposure, iuGC animals emitted more USVs and 
remained hyper-reactive over time (Fig.12). The pattern of 22 kHz USV emission in both groups 
was interesting since immediately after the lights were turned off, both groups emitted more 
negative vocalizations, indicative of the consolidated association with the electric shock 
(Fig.12). 
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Figure 12 - Prenatal administration of iuGC leads to enhanced fear response. Number of 22 kHz of USVs over 
time emitted during the test da; the iuGC emitted more 22 kHz calls than CONT animals after the second cue 
exposure and remain over-reactive until the end of the test. nCONT=8; niuGC=8; CONT=Controls; iuGC=in utero 
glucocorticoids; 
 
4.2. Effects of iuGC treatment on social behavior of offspring 
In order to asses if iuGC treatment affects social interaction, we performed different 
social paradigms. The first protocol consisted in analysing pup-mother interaction through 40 
kHz USVs recording. When the protocol was performed in the light period (08:00 a.m.) no 
differences were found between groups, except on day 7 (Fig. 13A, F1,36=0.14, P=0.7079, day 
7: t=2.656, P<0.05). Relatively to the dark phase of the cycle (08:00 p.m.), once again, we did 
not observe differences between groups (Fig. 13B, F1,32=1.85, P=0.1835). 
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Figure 13 - Effect of iuGC treatment on pups behavior. Number of 40 kHz USVs during light phase (A) and dark 
phase (B). No differences were found between groups, in both periods, during 5 min of protocol. Light 08:00 
a.m.: day 3 - nCONT=5; niuGC=5; day 7 - nCONT=7; niuGC=10; day 15 - nCONT=7; niuGC=10; Dark 08:00 p.m.: day 3 - nCONT=4; 
niuGC=4; day 7 - nCONT=6; niuGC=9; day 15 - nCONT=7; niuGC=10; CONT=Controls; iuGC=in utero glucocorticoids. 
 
To evaluate social behavior in juveniles, we performed the tumble and play protocol. 
Familiar (one rat with is sibling pair) iuGC pairs emited less USVs when compared with familiar 
control animals (Fig.14, t=2.375, P=0.0336). In the case of unfamiliar pairs, they presented 
the same trend as familiar pairs (Fig.14, t=1.802, P=0.0893). Surprisingly, the CONT-iuGC 
pairs elicited less positive 50 kHz vocalizations than the unfamiliar CONT-CONT pair and 
unfamiliar iuGC-iuGC pair (Fig.14, t=4.124, P=0.0004, t=1.850, P=0.0778, respectively).  
C
O
N
T
-C
O
N
T
u
iG
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
100
200
300
400
500
***
Familiar Unfamiliar
*
N
u
m
b
e
r 
o
f 
5
0
 k
H
z
 U
S
V
s
 
Figure 14 - GC exposure leads to a decrease in a number of positive calls during tumble and play 
protocol. Both familiar and unfamiliar iuGC-iuGC emitted less than CONT-CONT pairs. Interestingly, the CONT-
iuGC present a decrease in the 50 kHz emission compared with unfamiliar iuGC-iuGC and CONT-CONT pairs. 
nCONT-CONT= 11;  niuGC-iuGC= 8; nCONT-iuGC= 16; CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P 
<0.001. 
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We also evaluated other parameters of social behavior, namely pouncings (play 
solicitation), pinnings (acceptance to play) and social exploration, during the 15 min of the test. 
Familiar iuGC pairs have a trend to solicit less and performed less pinnings that CONT pairs 
(Fig.15A, t=1.525, P=0.1513; Fig.15B, t=2.973, P=0.0108, respectively). Similarly, unfamiliar 
iuGC pairs requested less to play (Fig.15A, t=3.032, P=0.0075), and pinned less when 
compared with unfamiliar CONT pairs (Fig.15B, t=3.424, P=0.0032). This was complemented 
by analysis of the percentage of positive responses to play solicitation. Once again, iuGC 
presented a decrease in the percentage of play responses when compared with CONT pairs 
(Fig.15C, Familiar: t=2.615, P=0.0187, Unfamiliar: t=2.220, P=0.0403). Surprisingly, CONT-
iuGC pairs pounced and pinned more than iuGC pairs (Fig.15A, t=6.439, P<0.0001; Fig.15B 
t=3.634, P=0.0015, respectively). Interestingly, CONT-iuGC pairs spent more time in social 
exploration than unfamiliar CONT-CONT (Fig.15D, t=2.882, P=0.0080). Furthermore, no major 
differences were found in social exploration time (Fig.15D) and latency to the first occurrence 
of social interaction (Fig.15E). 
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Figure 15 - Prenatal administration of dexamethasone leads impaired juvenile social behavior. Number of 
pouncings (A), pinnings (B) and percentage of response to play solicitation (C), duration of social exploration (D) 
and latency (E) to perform one of the parameters analysed during tumble and play protocol. Familiar iuGC pairs, 
present a trend to solicit less, while, the unfamiliar iuGC pair solicit statistically less than CONT animals. iuGC 
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pairs, both familiar and unfamiliar, present less pinning and a inferior response to play solicitation when 
compared with the CONT pairs. Unexpectedly, CONT-iuGC pairs present an increase in pouncing, pinning and 
spend more time in social exploration than iuGC and CONT pairs. No major differences were found in latency. 
nCONT-CONT= 11;  niuGC-iuGC= 8; nCONT-iuGC= 16; CONT=Controls; iuGC= in utero glucocorticoids; *P <0.05, ** P <0.01, *** 
P <0.001. 
 
Analyzing the responses in terms of percentage of play solicitation and acceptance, in 
the CONT-iuGC pairs, we could observe that iuGC animals displayed inferior play solicitation in 
comparison with CONT animals (Fig. 16A; t=5.637, P<0.0001), and a trend for a decrease of 
pinning responses (Fig. 16B; t= 2.014, P=0.0530). In conformity, iuGC animals presented a 
significant reduction in the response to play solicitation when compared to controls (Fig. 16C; 
t=2.163, P=0.0389). Thus, iuGC animals were not only likely to initiate a play session but were 
also less likely to respond when solicited by a partner. No differences were found in social 
exploration (data not shown). 
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Figure 16 - Prenatal administration of iuGC leads to impaired juvenile social behavior. Percentage of pouncings 
(A), pinnings (B) and response to play solicitation (C) during tumble and play, concerning the CONT-iuGC pairs. 
The iuGC animals pounce and pin less than CONT, leading to a lower percentage of response to play solicitation. 
nCONT=16; niuGC=16; CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001. 
 
4.3. Effects of iuGC treatment on adult social behavior 
Besides appetitive situations, 50 kHz USVs are also emitted after short periods of 
separation from conspecifics, as a communicative function. Separated animals, which can see 
each other, one in a new cage, other in the home cage, emit 50 kHz USVs, suggesting an 
affiliative communicative function of 50 kHz USVs, namely to (re)establish or to maintain social 
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contact (Wohr et al., 2008). During this separation, iuGC animals had a trend to emit less 50 
kHz USVs than CONT animals (Fig.17A, new cage: t=2.452, P=0.0578, home cage: U=6.5, 
P=0.7715). After this period of separation, animals were reunited and social behavior was 
measured. Regarding the USVs, we did not find differences between pairs (Fig.17A, t=0.4292, 
P=0.6828). Once again, the iuGC-iuGC pairs pounced (Fig.17B, t=2.598, P=0.0408) and 
pinned less compared to CONT pairs (Fig.17C, U=0.5, P=0.0408). In agreement, response to 
play solicitation was lower in iuGC animals (Fig.17D, U=1, P=0.0591). No statistical 
differences were found in latency to first approach and duration of social exploration, though it 
was observed a trend for an increased latency iuGC pairs (Fig.17F, t=1.501, P=0.1840) and 
reduced social exploration (Fig.17E, U=3, P=0.2).  
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Figure 17 - Prenatal administration of GC leads to an impairment in adult social behavior. Number of 50 kHz 
USVs during a period of separation and reunion (A), characteristics of social behavior, pouncing (B), pinning (C), 
response to play solicitation (D), duration of social exploration (E) and (F) latency to the first occurrence of social 
interaction. No differences were found in USVs measurements. Regarding the social behavior, iuGC animals 
present a reduction in the number of pouncing, pinning and in the percentage of response to play solicitation 
when compared with CONT pairs. nCONT=4; niuGC=4; CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P 
<0.01, *** P <0.001. 
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4.4. Effects of iuGC treatment on endocannabinoid, opioid and 
dopaminergic circuits 
As mentioned before, opioid/endocannabinoid/dopaminergic circuits are important for 
emotional behaviors. In order to assess if iuGC treatment affects these circuits, we analysed, 
by western blot the expression of opioid, endocannabinoid and dopamine receptors in three 
different areas (AMY, NAcc and HPT). 
In the AMY, we found no statistical differences regarding the levels of dopamine 
receptor 1 (Drd1). The non-glycosylated form (45 kDa) and the glycosylated receptor (75 kDa) 
of dopamine receptor 2 (Drd2), were more expressed in iuGC animals (Fig.18C, 45 kDa: 
t=2.678, P=0.0215, 75 kDa: U=40, P=0.0240). Concerning the opioid receptors, the levels of 
µ opioid receptor type 1 (MOR1) and k opioid receptor type 1 (KOR1) were higher in iuGC 
when compared with CONT animals (Fig.18E, U=1, P=0.0023; Fig.18G, t=4.8, P=0.001, 
respectively). The endocannabinoid receptor type 1 (eCB1), appeared not to be affected in the 
AMY of iuGC animals. No differences were found in the 53 kDa isoform of the receptor 
(Fig.18I, t=0.1943, P=0.8498) and in the glycosylated (64 kDa) receptor (Fig.18I, t=0.03838, 
P=0.9701). 
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Figure 18 - Expression of dopamine, opioid and endocannabinoid receptors in the amygdala (AMY). No 
differences were found in the expression of Drd1 (A) and eCB1 (I). The levels of expression of Drd2 (C), MOR1 (E), 
KOR1 (G) were different in both groups, with a higher expression in the iuGC animals. Representative immunoblot, 
of Drd1 (B), Drd2 (D), MOR1 (F), KOR1 (H) and eCB1 (J). nCONT=7; niuGC=7; CONT=Controls; iuGC=in utero 
glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001. 
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In the NAcc, no differences were found regarding Drd1 expression (Fig.19A). Drd2 
precursor (35 kDa), and the non-glycosylated form (45 kDa), were more expressed in iuGC 
than in CONT animals (Fig.19C, 35 kDa: U=12, P<0.0001, 45 kDa: t=3.090, P=0.0094, 
respectively). The MOR1 presented a trend to be reducely expressed (Fig.19E, t=1.527, 
P=0.1549), while KOR1 was highly expressed in the iuGC rats (Fig.19G, t=2.656, P=0.0224),   
 
Figure 19 - Impaired dopamine receptor 2 (Drd2) and k opioid receptor 1 (KOR1) expression, on the nucleus 
accumbens (NAcc), of iuGC animals. No differences were found in the expression of Drd1 (A) and MOR1 (E) in the 
NAcc. Representative immunoblot, of Drd1 (B), Drd2 (D), MOR1 (F) and KOR1 (H). nCONT=7; niuGC=7 (in KOR1 
niuGC=6); CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001. 
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In the HPT, we found no differences in Drd1 (Fig.20A), nor Drd2 (Fig.20C, 45 kDa: 
t=0.3241, P=0.7515; 75 kDa: t=0.5173, P=0.6143). In the same way, MOR1 and KOR1 were 
similar between groups (Fig.20E, U=75, P=0.4520; Fig.19G, t=1.280, P=0.2124, 
respectively). Due to technical problems the expression of eCB1 receptors was not analyzed in 
the NAcc and HPT. 
 
Figure 20 – Hypothalamic levels of Drd1 (A), Drd2 (C), MOR1 (E), and KOR1 (G). No differences were found. 
Representative immunoblot, of Drd1 (B), Drd2 (D), MOR1 (F) and KOR1 (H) in control and iuGC animals. nCONT=7; 
niuGC=7; CONT=Controls; iuGC=in utero glucocorticoids. 
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4.5. Dopaminergic modulation of the emotional condition in iuGC animals 
Considering some results showing that L-DOPA treatment could revert some of the 
behavioral alterations of iuGC animals (Rodrigues et al.,2011b), and considering the fact that 
the dopaminergic circuits seem to be crucial for both emotional and social behaviors, we 
decided to treat the animals with L-DOPA. The administration of L-DOPA/carbidopa (24mg/kg) 
by oral gavage (4h before tests), started three days before the behavioral tests, in order to 
normalize dopamine levels as previously shown (Rodrigues et al., 2011b). Besides the results 
from animals under L-DOPA treatment, we will present side by side the results of the basal 
conditions (previously shown in the sections 4.1 to 4.3). Due to lack of time, procedures in 
basal situation and under L-DOPA treatment were performed with different sets of animals, 
except for the L/D box test.  
 
Depressive-like-behavior 
To assess if dopamine normalization could revert the depressive-like behavior, we 
submitted animals to the FST test. L-DOPA treatment was able to fully revert the depressive-like 
behavior observed previously (Fig.21B, immobility: t=0.3583, P=0.7243; latency: U=44, 
P=0.6842; climbing: t=1.249, P=0.2287).   
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Figure 21 - Reversion of depressive-like-behavior of iuGC animals by L-DOPA treatment. The graph represents 
the total time immobile, latency to stay immobile and total time climbing of CONT and iuGC animals, without (A) 
and under L-DOPA treatment (B). No differences were found between groups, in L-DOPA treated animals (B). (A) 
is reproduced from Fig.6. nCONT=10; niuGC=10; CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P 
<0.01, *** P <0.001. 
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We also performed the food anticipation paradigm with the subjects treated with L-
DOPA. The curves of both groups were very different (Fig.22B, F1,108 =18,79, P < 0.0001); iuGC 
animals emitted much more positive calls than CONT animals. On the seventh day, we also 
measured the USVs during the extinction period and we found no major differences (Fig.22D, 
cue exposure: t=6731, P=0.5094, extinction: t=0.7340, P=0.4730).  
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Figure 22 - Effects of L-DOPA administration in USVs emission in anticipation to food. Number of positive 55 kHz 
calls over the six consecutive days, under basal conditions (A) and L-DOPA treatment (B). In basal situation, iuGC 
emitted less than CONT animals. After L-DOPA treatment, iuGC emitted more than CONT animals over time. 
Number of 50 kHz USVs on seventh day, during cue exposure and extinction periods, under basal situation (C) 
and under L-DOPA treatment (D). During cue exposure iuGC animals emitted less than CONT under basal 
situation. While with L-DOPA treatment, no major differences were found in both periods. (A) and (C) are 
reproduced from Fig.8. Basal situation: nCONT=8; niuGC=8; L-DOPA treatment: nCONT=10; niuGC=10; CONT=Controls; 
iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001. 
 
Anxiety 
We also analysed the effect of L-DOPA treatment on anxious behavior. Regarding the 
light/dark box test, no differences were found in the time spent (Fig.23B, dark: t=1.228, 
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P=0.2385; light: t=1.587, P=0.1334) and distance travelled (Fig.23A, dark: t=1.384, 
P=0.1854; light: t=1.825, P=0.0867) in the dark and light compartments. 
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Figure 23 - Effects of L-DOPA administration on light/dark box test. Time spent in the dark and light 
compartment, under basal situation (A) and under L-DOPA treatment (B). In basal situation, iuGC animals spent 
more time in the dark compartment than compared with CONT; with L-DOPA treatment no differences were 
found. Distance covered in the light/dark box test in a basal situation (C) and under L-DOPA treatment (D). No 
differences were found in both conditions. (A) and (C) are reproduced from Fig.9. Basal situation: nCONT=8; niuGC=8; 
L-DOPA treatment: nCONT=10; niuGC=10; CONT=Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P 
<0.001.   
 
In treated animals both CONT and iuGC groups did not emit any aversive 22 kHz calls 
during confinement (data not shown). In accordance, both groups displayed extremely reduced 
freezing (Fig.24, U=22, P=0.7658).  
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Figure 24 - Reversion of anxious phenotype of iuGC animals by L-DOPA treatment. Freezing behavior performed 
in a novel and confined cage during 11 min by each group, in a basal situation (A) and under L-DOPA treatment 
(B). In basal situation no differences were found on both days. Under L-DOPA treatment, both groups present 
reduced freezing, once again, no differences were found between groups on day 1. In the second day, animals do 
not stay immobile. (A) is reproduced from Fig.10B. Basal situation: nCONT=8; niuGC=8; L-DOPA treatment: nCONT=8; 
niuGC=8; CONT=Controls; iuGC=in utero glucocorticoids. 
 
Fear 
L-DOPA treatment was able to revert the increased 22 kHz USVs emission during 
conditioning day (Fig.25B, t=0.6813, P=0.5076), as well as the augmented freezing 
percentage (Fig.25D, t=0.7117, P=0.4884). 
On the testing day, no major differences were found in L-DOPA treated animals but this 
was more likely a result of changes in control animals rather than in iuGC animals (USVs: 
Fig.25F, t=0.6409, P=0.5319; Freezing: Fig.25H, t=0.2744, P=0.7884).  
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Figure 25 - Effect of L-DOPA treatment on fear conditioning paradigm. Number of 22 kHz USVs emitted during 
conditioning day in basal situation (A) and under L-DOPA treatment (B). In the conditioning day, after the initial 
phase, the animals were submitted to 6 pairs of light/shock. In basal situation, iuGC animals emitted more than 
CONT (A), while with L-DOPA treatment no differences were found between groups (B). Regarding percentage of 
time that animal remained immobile on the conditioning day, under basal condition, iuGC animals remained more 
time immobile compared with CONT (C), while under L-DOPA treatment no differences were found (D).  On the 
test day, after the first 3 min, animals were exposed 6 times to light but no shock was given. Once again, iuGC 
animals emitted more negative 22 kHz calls than CONT, under basal situation (E). With L-DOPA treatment no 
differences were found (F). In basal situation, iuGC animals remained more time immobile compared with CONT 
(G). Under L-DOPA treatment no differences were found between groups (H). (A),(C),(E) and (F) are reproduced 
from Fig.11. Basal situation: nCONT=8; niuGC=8; L-DOPA treatment: nCONT=8; niuGC=8; CONT=Controls; iuGC=in utero 
glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001. 
 
On the testing day, in the initial 100 seconds we detected no emission of negative 
USVs. Following the first time that the lights were ON, both groups increased the number of 
vocalizations to a similar level (Fig.26).  
 
Figure 26 - Effects of L-DOPA administration on both groups in fear conditioning paradigm. Number of 22 kHz of 
USVs over time emitted during the test day under basal conditions (A) and L-DOPA treatment (B). The iuGC 
animals emitted more negative 22 kHz calls than CONT animals after the second cue exposure and remain until 
the end of the test (A) in a basal situation. With L-DOPA treatment, both groups increase the number of 22 kHz 
USVs similarly. (A) is reproduced from Fig.12. Basal situation: nCONT=8; niuGC=8; L-DOPA treatment: nCONT=8; niuGC=8; 
CONT= Controls; iuGC=in utero glucocorticoids. 
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4.6. Dopaminergic manipulation of social behavior in iuGC animals 
To further ascertain if it is possible to revert the social behavior impairments observed 
during tumble and play test, we treated juvenile animals with L-DOPA using a similar protocol 
as described for adult animals. During the tumble and play protocol we found no major 
differences between CONT and iuGC pairs, both in familiar and unfamiliar conditions (Fig.27B, 
familiar pairs: t=0.4343, P=0.670; unfamiliar pairs: t=0.3815, P=0.7085).   
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Figure 27 – Dopaminergic manipulation of social behavior. Number of positive 50 kHz USVs emitted during 
tumble and play protocol, in basal situation (A) and under L-DOPA treatment (B). Social play elicited less positive 
calls in iuGC-iuGC pairs when compared with CONT-CONT pairs, in a basal situation. Under L-DOPA treatment no 
differences were found between all groups tested. (A) is reproduced from Fig.14. Basal situation nCONT-CONT= 11;  
niuGC-iuGC= 8; nCONT-iuGC= 16; L-DOPA treatment: nCONT-CONT= 8;  niuGC-iuGC= 8; nCONT-iuGC= 8; CONT= Controls; iuGC=in utero 
glucocorticoids, *P <0.05, ** P <0.01, *** P <0.001. 
 
Similarly, no major differences were found between groups in terms of social behavior. 
Both groups presented similar patterns of poucning (Fig.28D, familiar: U=47, P=0.5967; 
unfamiliar: t=0.7253, P=0.4802), pinning (Fig.28F, familiar: t=0.5424, P=0.5939, unfamiliar: 
t=1.007, P=0.3308) and percentage of response to play solicitation (Fig.28H, familiar: 
t=0.9496, P=3556; unfamiliar: t=1.887, P=0.08). Interestingly, we found an effect of L-DOPA 
treatment on the latency to perform social play behavior, all groups take less time to engage in 
social play, especially the unfamiliar iuGC pairs.  
56 
 
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
10
20
30
40
**
**
Familiar Unfamiliar
*
N
u
m
b
e
r 
o
f 
P
in
n
in
g
s
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
10
20
30
40
Familiar Unfamiliar
N
u
m
b
e
r 
o
f 
P
in
n
in
g
s
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
10
20
30
40
50
Familiar Unfamiliar
**
***
***
Basal Situation
N
u
m
b
e
r 
o
f 
P
o
u
n
c
in
g
s
L-DOPA
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
10
20
30
40
50
Familiar Unfamiliar
N
u
m
b
e
r 
o
f 
P
o
u
n
c
in
g
s
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
10
20
30
40
50
Familiar Unfamiliar
**
L
a
te
n
c
y
 (
s
)
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
10
20
30
40
50
*
Familiar Unfamiliar
L
a
te
n
c
y
 (
s
)
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
20
40
60
80
100
Familiar Unfamiliar
**
%
 o
f 
re
s
p
o
n
d
e
 t
o
 p
la
y
 s
o
lic
it
a
ti
o
n
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-C
O
N
T
iu
G
C
-i
u
G
C
C
O
N
T
-i
u
G
C
0
20
40
60
80
100
Familiar Unfamiliar
%
 o
f 
re
s
p
o
n
s
e
 t
o
 p
la
y
 s
o
lic
it
a
ti
o
n
A B
C D
E F
G H
 
57 
 
Figure 28 - Reversion of social behavior impairment observed in the iuGC treated animals by L-DOPA 
administration. In a basal situation, the iuGC pairs pounce less (A), pin less (C) and having as a result inferior 
percentage of response to play solicitation (G), when compared with CONT pairs. No differences were found in the 
number of pouncings (B), pinnings (D) and percentage of response to play solicitation (H) between groups, under 
L-DOPA treatment. Interestingly, the latency to engage in social play is inferior under L-DOPA treatment (F), 
especially unfamiliar iuGC pairs, while in a basal situation no differences were found (E). (A),(C),(E) and (G) are 
reproduced from Fig.15. Basal situation nCONT-CONT= 11;  niuGC-iuGC= 8; nCONT-iuGC= 16; L-DOPA treatment: nCONT-CONT= 8;  
niuGC-iuGC= 8; nCONT-iuGC= 8; CONT= Controls; iuGC=in utero glucocorticoids; *P <0.05, ** P <0.01, *** P <0.001. 
 
Regarding the CONT-iuGC pairs no major differences were found between groups, in 
terms of percentage of solicitation to play (pouncings: Fig.29B, t=0.6452, P=0.5292) and 
acceptance (pinning: Fig.29D, t=1.501, P=0.1555) and in the response to play solicitation (Fig. 
29F; t=0.8006, P=0.4367).  
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Figure 28 - Reversion of social behavior impairment observed in the iuGC treated animals, by L-DOPA 
administration. iuGC animals perform less solicitation to play (A) and respond less (C) having as consequence a 
lower percentage of response to play solicitation (E) when compared with CONT subject, under basal conditions. 
With L-DOPA treatment, no differences were found between animals, in percentage of pouncing (B), pinning (D) 
and response to play solicitation (F). (A),(C) and (E) are reproduced from Fig.16. Basal situation: nCONT-iuGC= 16; L-
DOPA treatment: nCONT-iuGC= 8; CONT=Controls; iuGC= in utero glucocorticoids; *P <0.05, ** P <0.01, *** P 
<0.001. 
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5. Discussion 
 
5.1. Stress effects in affective state 
Stress can have remarkably different outcomes, depending on the time of exposure, 
type, length and intrinsic (epi/genetic) factors of the individual.  Early life stress has a powerful 
programming effect and leads to the appearance of several neuropsychiatric conditions later in 
life, especially those involving the reward circuitry such as anxiety, depression and reward 
disorders (e.g. addiction) (Roque et al., 2011, Oliveira et al., 2006, Rodrigues et al., 2011b).  
Psychological resilience is known as a relatively stable personality trait characterized by 
the capability to bounce back from negative experiences and by flexible adaptation to the ever-
changing demands of life (Block and Kremen, 1996). It is well-known that positive affective 
states, as studied longitudinally in humans, confer resilience to depression and anxiety and 
lead to an increase in overall health and a decrease in mortality from all causes (Lyubomirsky 
et al., 2005). In addition, individuals with high levels of happiness or trait positive affect appear 
to be more likely to approach reward activities, especially social ones. On the other hand, 
socialization is itself a factor that elicits highest levels of positive affect state (Stone et al., 
2006).  
In humans, positive affective states are measured primarily via subjective self-report 
and behaviorally by facial/vocal displays. In laboratory animals this is not possible, we can only 
rely on empirical observations. However, it has been proposed that ultrasonic vocalizations are 
potential tools to measure when animals are in a positive affective state. For example, several 
studies show that 50 kHz USVs are correlated with positive affective state in rats. Social 
interaction, anticipation to food, drugs of abuse and electrical brain stimulation reward, 
increase number of positive 50 kHz calls, in another word, increase positive affective state 
(Burgdorf et al., 2000, Burgdorf et al., 2001, Burgdorf et al., 2008). As expected, these calls 
are decreased by aversive stimuli such as social defeat, frustative non-rewarding situations, 
sickness and foot shock (Burgdorf et al., 2000, Burgdorf et al., 2008).  
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By measuring the USVs in combination with standard behavioral tests, we showed that 
in utero glucocorticoid exposed animals present a prominent anxious phenotype, depressive-
like behavior and emotional over-reactivity (enhanced fear response).  
 
Depressive-like behavior 
Repeated stress and HPA axis hyperactivation have been associated with the 
development of depression (Tsigos and Chrousos, 2002). iuGC animals have an impairment in 
the HPA activity (Oliveira et al., 2006), which could potentiate the appearance of depressive-
like behavior. We performed two different behavioral tests to ascertain depressive-like behavior 
of iuGC animals – the FST and USV emission in anticipation to a rewarding event (food). 
During the FST, we observe an increase in immobility time and decreased time to immobility, 
suggesting that prenatal dexamethasone treatment leads to a depressive-like state, as 
previously reported (Roque et al., 2011). While immobility and latency are considered an 
indicator of depression, several articles suggest that climbing behavior is a defensive-escape 
response to potentially dangerous situations than a characteristic of depressive-like-behavior. A 
similar increase in the immobility time was observed in other models of prenatal DEX exposure 
(dexamethasone in drinking water from day 15 of pregnancy) (Hauser et al., 2009), suggesting 
that this is a common trait of GC exposed animals. 
One other core symptoms of depression is anhedonia, i.e., is the inability to obtain 
pleasure from enjoyable experiences, such as eating, play, sexual behavior or social 
interactions (Moreau, 1997). More recent studies have highlighted the need to consider 
different aspects of pleasant behavior, such as motivation or desire to engage in an activity 
(“motivational anhedonia”) as compared to the level of enjoyment of the activity itself 
(“consummatory anhnedonia”) (Treadway and Zald, 2011). When assessed for anhedonia, in 
the anticipation to food paradigm, iuGC animals emitted less positive USVs than CONT rats, 
throughout time when exposed to a cue that predict food. Note that at day 1 no differences 
were found, as expected, since the animals still do not associate the stimuli with the reward.  
These results may indicate that in utero glucocorticoid exposure leads to a diminished 
motivational status. Indeed it has been shown that prior chronic corticosterone exposure to 
mice or rats leads to reduction in food-motivated instrumental acquisition and performance, 
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i.e., lack of motivational drive (Olausson et al., 2012). We also evaluated the response of the 
animals to a physical enriched environment, which could be seen as a measure of 
consummatory anhnedonia, although some validation studies are still required. While CONT 
animals decreased the number of positive USVs throughout days, potentially indicating that 
they lost “interest” in the environment (habituation), iuGC animals seem to increase calls, 
which may be a result of their anxious behavior, though more studies need to be performed. 
 
Anxiety 
Depression has been linked to stress exposure and is frequently comorbidily 
associated with anxiety (Aina and Susman, 2006, Tsigos and Chrousos, 2002), suggesting an 
overlapping pathway of neuronal (dys)function between these affective disorders. Avoidance of 
the open arms in the elevated plus maze (EPM) is considered the goal standard index of 
anxiety-related behavior and it has been previously shown that iuGC animals avoid open arms 
(Oliveira et al., 2006). In order to further confirm the anxious phenotype, we perform the 
light/dark box test. iuGC group presents a decrease in the time spend in the anxiogenic light 
compartment, indicative of higher anxiety levels. In addition, we also observe that iuGC 
subjects emit more 22kHz aversive vocalizations than controls in a novel and confined cage, 
importantly, that these differences are eliminated with habituation. These data are accordingly 
with information shown by Borta et al that rats that are highly anxious tented to vocalize more 
often and present more freezing time (though we were unable to measure this parameter) 
during an aversive stimulus, than rats that display low anxiety-like behavior (Borta et al., 2006). 
 
Fear 
In the fear conditioning paradigm that we used, flight or avoidance responses to 
signaled shock is considered to reflect fear rather than anxiety. We observe that iuGC animals 
emitted more negative calls than CONT when presented with paired cue-shock stimuli. This 
may suggest different pain sensitivity, which is in accordance with preceding literature showing 
that chronic stress induces a hypersensitivity to painful stimuli (Metz et al., 2001, D'Amato and 
Pavone, 2012), but may also reflect a general emotional over-reactivity in these animals. In 
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further support of this last idea, iuGC animals also emit more negative calls and present an 
increase in freezing percentage in response to cue that predict a harmful stimulus and during 
inter-stimulus-interval. Both groups emitted negative USVs in a context associated with such 
painful experience and iuGC animals present a trend for increased contextual emission. 
Besides the fact that USVs reflect the animals affective state, some reports hypothesized that 
they also have a communicative function (Wohr et al., 2008). Indeed, the 22 kHz calls in 
response to a predator, might serve as “alarm calls”, which determines the probability of their 
emission in the presence of listeners, namely rats from the same colony. However, in our 
experiments, fear conditioning protocol was performed inside of a ventilated, sound-attenuated 
chamber in a room with no other animals present, which suggests that rather than alarm calls, 
these 22kHz USVs are emitted due to a negative affective state of the animal. 
These results show that early life stress modulates the response to a novel and 
painful/anxiogenic stimulus, which is supported by previous works that showed that prenatal 
stress impair the organism’s resilience to stress in adulthood (Oliveira et al., 2006). 
 
5.2. Impact of prenatal stress on social/affective behaviors  
Charles Darwin wrote: ‘Happiness is never better exhibited than by young animals, 
such as puppies, kittens, lambs, &c., when playing together, like our own children’ (Darwin, 
1871/1936)  
All mammals engage in some form of social play behavior, spend time in these 
activities with no understandable meaning than having fun, suggesting that social play is 
important for happiness/positive affective state. In humans, it was found that happy individuals 
are more likely to enjoy their leisure activities and social interactions, and to be more satisfied 
with their activities in general (Lyubomirsky et al., 2005). 
We hypothesized that the emotional and motivational status of the animal could 
influence social interaction, thus we assessed iuGC animals in different social paradigms. In 
maternal-pup induced vocalizations, we did not find major differences between groups, except 
for day 7, where iuGC litters emitted significantly less than controls. This may indicate some 
degree of social deficit, although more studies need to be performed, such as for example pup-
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mother vocalization upon separation and reunion. In juvenile animals, social deficits were 
obvious and remained until adulthood. In the tumble and play protocol, juvenile iuGC rats 
presented a trend to a reduced number of 50 kHz calls when playing with their familiar pair in 
comparison with CONT pairs, which may indicate some degree of anhedonia. Concerning the 
unfamiliar pairs, social interaction with a novel partner may elicit negative feelings - indicative 
of anxiety, and, together with the lack of motivation, may further impair social behavior. The 
unfamiliar iuGC pairs play less and emit less quantity of positive USVs, opposite pattern was 
observed in CONT pairs. Regarding the CONT-iuGC pair, once again, the iuGC pounce 
significantly less and present a decrease in play response in comparison with CONT partners. 
This is in agreement with data suggesting that social behavior and vocalization emission is 
greatly dependent on the partner (Trezza and Vanderschuren, 2008b, Wright et al., 2010). In 
adulthood, this play protocol involves some constraints because animals already present 
aggressive behavior and fight instead of playing to establish dominance/submissive hierarchy 
(Vanderschuren et al., 1997). Thus we assessed communicative function, another indirect 
measure of social interaction. Isolated iuGC animals have a trend to emit less calls than 
controls whereas animals that remain in their home cage present no differences. However, 
upon reunion, iuGC group presents remarkably different social interaction, presenting a 
decrease in social behavior. These results are further supported by previous findings that 
indicate that early gestational exposure to dexamethasone in marmots (Hauser et al., 2007), in 
pig sows (hydrocortisone) (Kranendonk et al., 2006) and in rats (Kleinhaus et al., 2010) 
reduces social affiliative behavior in the offspring.  
These findings showing that in utero glucocorticoids causes a reduction in motivational 
drive/lack of pleasurable feelings in rewarding situations such as social interaction, are in 
further support for the depressive-like behavior/anhedonia status observed iuGC animals. 
Altogether, these results may be relevant in the context of neuropsychiatric conditions 
that present impaired social behavior such as schizophrenia and autism (Cannon et al., 2008, 
Trezza and Vanderschuren, 2008b), in which both have been proposed to have a 
neurodevelopmental cause, and where stress may aggravate/potentiate the symptoms (Gillott 
and Standen, 2007, Seghers and Docherty, 2009).  
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5.3. Endocannabionid, opioid and dopaminergic correlates 
Mesolimbic dopaminergic transmission is regulated at several levels, and converging 
evidence shows a strong overlap and interdependence with endocannabinoid system (Hill and 
McEwen, 2010, Gorzalka et al., 2008). As mentioned before the 
endocannabinoid/opioid/dopaminergic circuits are extremely important in the modulation of 
emotional and social behaviors.  
It is known that endocannabinoid and dopaminergic system have overlapping circuits, 
but this is not observed between endocannabinoid and opioid system, actually, it has been 
proposed that they have partially distinct neural mechanisms (Trezza and Vanderschuren, 
2008b). Endocannabinoid system is important for the regulation of the HPA axis, like 
mentioned before, but also, its antagonism leads to development of anxiety and depressive-like 
behavior (Parolaro et al., 2010). It is known that activation of endocannabinoid receptor type 1 
(eCB1) receptors in the prefrontal cortex and ventral hippocampus induces an anxiolytic 
response (Moreira et al., 2009, Rubino et al., 2008), while his activation on the amygdala and 
dorsal hippocampus raises an anxiogenic response (Rubino et al., 2008, Roohbakhsh et al., 
2007). In the amygdala of iuGC animals we did not find significant differences in eCB1. 
Unfortunately, due to technical problems, we were unable to quantify CB1 in other relevant 
areas (NAcc and HPT). Recent work has shown that endocannabinoids in the amygdala and 
NAc are crucial for social behaviors (Trezza et al., 2012). Interestingly, results obtained by our 
group showing that endocannabinoid, anandamine (AEA), is remarkably reduced in the NAcc of 
these animals, may explain their altered social (and emotional?) behavior. To validate this idea, 
we could administer in loco or systemically endocannabinoids in iuGC animals and observe if 
we were able to ameliorate the phenotype. 
The interaction between endocannabinoid system and opioid was widely study in rats 
in the modulation of reward processes. The endocannabinoid system has been shown to be 
involved in the reinforcing and dependence-producing properties of opioid drugs, and µ-opioid 
receptors have been implicated in the motivational effects of cannabinoids (Fattore et al., 
2005, Maldonado et al., 2006). In addition, stimulation of µ opioid receptors (MOR) in the AMY 
enhances approach and food consumatory behaviours at cues (Mahler and Berridge, 2009). 
Surprisingly, and contrary to what we expected, iuGC animals present a significantly increased 
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expression of MOR in the AMY. Such de-regulation can explain the alterations in the motivation 
towards food, though these results are somehow contra intuitive. 
Concerning the k opioid receptors (KOR), it is known that dysregulation of KOR 
signalling within neural circuits involved in mood and motivation contributes to depression and 
anxiety disorders (Knoll et al., 2011, Carlezon et al., 2009, Tejeda et al., 2012). In addition, 
fear conditioning and extinction regulate KOR mRNA expression in the AMY; and KOR 
antagonist in the basolateral amygdala can produce anxiolytic-like effects (Knoll et al., 2011), 
so, in theory, the observed higher levels of KOR could help explain the anxiogenic profile of 
these animals. 
It has been shown that MOR and KOR agonists have different effects on social 
behavior. The stimulation of MOR, but not KOR, enhances social play (Vanderschuren et al., 
1995b). Relatively, to the δ opioid receptor, only when in juvenile rats, are not involved in the 
regulation of social behavior (Vanderschuren et al., 1995b). Low levels of opioids in this brain 
region could explain a reduced stimulation of MOR and consequent social impairment. The 
current observation of increased levels of MOR may be a compensatory mechanism due to low 
levels of ligand, though this hypothesis needs to be validated.  
Regarding the NAcc, it is known that KOR activation in this brain region produces 
anhedonia without affecting the magnitude of fear (Muschamp et al., 2011). We also observe 
higher levels of KOR in this brain region, potentially explaining the observed anhedonia. 
Dopaminergic input in emotional behavior is undeniable but this input was less studied 
in the context of social behavior. Confirming previous results, we found that the mesolimbic 
dopaminergic circuit is significantly affected in iuGC animals. In our model, no differences were 
found in dopamine D1 receptor (Drd1), while we observe high levels of dopamine D2 receptor 
(Drd2) expression when compared with CONT animals in the NAcc and amygdala, as 
previously reported (Oliveira et al., 2012, Rodrigues et al., 2011b); such changes could 
underlie the enhanced fear conditioning of iuGC animals and the anhedonia. Previous works 
demonstrate that antagonism of Drd1 and Drd2 in the AMY may mediate the formation and the 
retention of newly-acquired fear associations, though our animals do not seem to present any 
change in this aspect of fear behavior.     
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5.4. Impact of dopaminergic manipulation 
Considering Drd2 changes and the reported hypodopaminergic status in iuGC animals 
(Rodrigues et al., 2011b), and the importance of correct dopaminergic tone for social and 
emotional manifestations, we decided to explore whether the behavioral impairments could be 
reverted by dopamine normalization. We administered L-3,4-dihydroxyphenylalanine (L-DOPA),  
a precursor of dopamine, by oral gavage daily. L-DOPA was given 4h prior to the behavioral 
tests to ensure the absence of side effects commonly associated with this drug. L-DOPA 
crosses the protective blood-brain barrier, and when it enters in the central nervous system, it 
is converted into dopamine by the enzyme DOPA decarboxylase.  
We found that systemic administration of L-DOPA reverts most of the emotional and 
social/affective deficits in iuGC group. L-DOPA reverted the depressive-like behavior in the FST 
and increased substantially the emission of positive calls in anticipation to food. This data is in 
accordance with previous reports that shown that patients with Parkinson’s disease (which 
reveal a depression like-behavior and anhedonia) during pramipexole (dopamine agonists) 
treatment present a significantly reduction in depression and anhedonia symptoms in addition 
to motor improvement (Constantinescu, 2008, Barone et al., 2010). Moreover, an anti-
depressive effect was proposed for L-DOPA in Parkinson´s disease patients (Maricle et al., 
1995) though contradictory reports are also found (Cools, 2006). 
Though we were expecting a positive effect in the depressive-like behavior, less/none 
effect was expected in the anxiogenic phenotype. Remarkably, L-DOPA treatment before the 
L/D box test abolished all the differences between groups; animals placed in an anxiogenic 
environment (confined cage) no longer emit 22 kHz calls emission and present no freezing. 
Importantly, it is known that dopamine D2 receptor is involved in the inhibition of 22 kHz 
ultrasonic vocalization (Bartoszyk, 1998) in a model of anxiety (Sanchez, 2003). L-DOPA 
supplementation and consequent normalization of Drd2 (Rodrigues et al., 2011b) could explain 
the decrease in USVs emission. Though we were not expecting this effect, previous literature 
showed that dopamine D2/D3 receptor agonist (ropinirole) had an anxiolytic-like activity in 
three models of anxiety (rat, mouse and marmoset) (Rogers et al., 2000).  
iuGC treatment impairs fear conditioning in adulthood, which is consistent with deficits 
found in the amygdalar function and memory consolidation for emotional experiences (Oliveira 
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et al., 2006). Surprisingly, our results are somehow contradictory since they show enhanced 
fear response in our animals. A possible explanation is the type of protocol that is slightly 
different in the two cases, or the fact that we are measuring different aspects of fear behavior. 
While Oliveira and colleagues showed impaired fear conditioning by a decrease in fear 
potentiated startle (augmentation of startle reflex by a fear stimulus), we are observing a “more 
direct response” to a cue predicting a fearful stimulus. Under L-DOPA treatment, iuGC group 
no longer presents differences from control group (both USVs and freezing %). These results 
are in agreement with previous articles that shown that dopamine D2 and dopamine D2/3 
receptor agonist are among the most potent inhibitor of footshock-induced ultrasonic 
vocalization (Bartoszyk, 1998). However, it is important to stress that control animals treated 
with L-DOPA emit much more negative USVs than non-treated animals. Since dopamine is 
crucial for the establishment and learning of fear conditioning, we might suppose that control 
animals (with normal dopaminergic input) boosted with more dopamine may present an overt 
response in the fear paradigm. 
In social behavior, L-DOPA did not have a major impact in the positive 50 kHz 
emission, however, play behavior increased substantially compared with animals in basal 
situation and, importantly, no differences were found between groups. When rats are tested for 
social play in a new cage, two different stimuli compete for their attention: an unfamiliar cage 
and unfamiliar test partner. When the animal is placed inside of the box with the unfamiliar test 
partner, it will first explore the unfamiliar test cage before engaging in social play, which leads 
to a temporary suppression of social behavior, although total levels of social play measured 
during the 15 min are not affected (Vanderschuren et al., 1995a). Interestingly, under L-DOPA 
treatment, the latency to engage in social play behavior is slightly lower, especially unfamiliar 
iuGC-iuGC pairs, when compared with animals on basal situation. Concisely, L-DOPA treated 
animals prefer to engage immediately in playful interactions with their partners instead of first 
investigating the new environment.  
In further support of dopaminergic importance in social behavior, it was shown that 
treatment with blockers of dopaminergic transmission, such as chlorpromazine or haloperidol, 
as well as low doses of apomorphine, decreases social play (Vanderschuren et al., 1997). 
Some works reveal that treatment with dopamine D3 receptor agonist do not affect social play, 
while the treatment with dopamine D2 receptor agonist has biphasic effects depending on the 
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dose: low levels increase, although higher levels decrease social play (Vanderschuren et al., 
1997). Since L-DOPA is a precursor, it will modulate the activity of more than one type of 
dopamine receptor, so an interesting approach would be to administer D2 specific 
agonists/antagonists to confirm if the behavioral impairment of iuGC animals occurs through 
this receptor. In addition it would be interesting to investigate the correlation between 
dopaminergic and opioid circuitry by eventually combining agonists/antagonists of these two 
pathways to ascertain their relevance and interconnectivity in emotional and social behaviors.  
 
In summary, we have found that prenatal glucocorticoids exposure leads to long-lasting 
anxious and depressive-like behavior and to impaired fear response, together with deficits in 
social interaction. Most of these behavioral deficits were reverted with dopamine normalization 
by L-DOPA administration by oral gavage. Moreover, our findings support the USVs 
measurement technique as a powerful tool to assess rodent emotional and affective status. 
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6. Futures perspectives 
 
As future experiments, we aim to better understand the key role and interplay between 
dopaminergic, opioid and endocannabinoid circuitries in both emotional and social behaviors. 
These goals can be achieved using several strategies: 
a) Administration of endocannabinoid, opioid and/or dopaminergic 
agonist/antagonists to further study the involvement of these neurotransmitters in 
the behavioural deficits observed (systemically and in loco in target brain regions 
of mesolimbic circuit). 
b) Study other dimensions of social interaction such as aggressive and sexual 
behaviors. 
c) Analyse social behaviour in other stress models (maternal separation, chronic 
stress) in order to understand the role of stress and the importance of the window 
of stress exposure for the development of social deficits. 
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